Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 1/20 | 0.35 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GSDMD | P57764 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11870803 | 0.80 | CA12 (0.33) | CA12CA1CA2CA9 | |
| SCHEMBL3078858 | 0.78 | ALDH1A1 (0.40) | ABCB11CYP2E1PTGS1HTTGSDMD | |
| SCHEMBL28369634 | 0.75 | ALDH1A1 (0.39) | ABCB11CYP2E1PTGS1HTTGSDMD | |
| SCHEMBL20819787 | 0.75 | ALDH1A1 (0.39) | ABCB11CYP2E1PTGS1HTTGSDMD | |
| SCHEMBL28773605 | 0.75 | ALDH1A1 (0.39) | ABCB11CYP2E1PTGS1HTTGSDMD | |
| SCHEMBL11563773 | 0.75 | ALDH1A1 (0.39) | ABCB11CYP2E1PTGS1HTTGSDMD | |
| SCHEMBL28773566 | 0.75 | ALDH1A1 (0.39) | ABCB11CYP2E1PTGS1HTTGSDMD | |
| SCHEMBL8677340 | 0.75 | ALDH1A1 (0.39) | ABCB11CYP2E1PTGS1HTTGSDMD | |
| SCHEMBL1057847 | 0.73 | — | — | |
| SCHEMBL11441509 | 0.69 | ABCB11 (0.42) | ABCB11CYP2E1PTGS1HTTGSDMD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5358703-A | Forming a paramagnetic complex with a dithiocarbamate and reduced iron ions; magnetic resonance imaging | MCW RESEARCH FOUNDATION, INC. (US) | 1994-10-25 | — | — | US | claimed |
| US-9112094-B2 | Copper tin sulfide and copper zinc tin sulfide ink compositions | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-08-18 | — | — | US | disclosed |
| US-20150118144-A1 | DISPERSIBLE METAL CHALCOGENIDE NANOPARTICLES | E I DU PONT NEMOURS AND COMPANY (US) | 2015-04-30 | — | — | US | disclosed |
| US-20140144500-A1 | SEMICONDUCTOR INKS FILMS, COATED SUBSTRATES AND METHODS OF PREPARATION | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-29 | — | — | US | disclosed |
| WO-2013172949-A1 | DISPERSIBLE METAL CHALCOGENIDE NANOPARTICLES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-11-21 | — | — | WO | disclosed |
| US-20130264526-A1 | MOLECULAR PRECURSORS AND PROCESSES FOR PREPARING COPPER INDIUM GALLIUM SULFIDE/SELENIDE COATINGS AND FILMS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-10 | — | — | US | disclosed |
| US-20130233202-A1 | INKS AND PROCESSES FOR PREPARING COPPER INDIUM GALLIUM SULFIDE/SELENIDE COATINGS AND FILMS | EI DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-12 | — | — | US | disclosed |
| US-20130095602-A1 | ATYPICAL KESTERITE COMPOSITIONS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-04-18 | — | — | US | disclosed |
| US-8366975-B2 | Atypical kesterite compositions | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-02-05 | — | — | US | disclosed |
| EP-2500088-A2 | Molecular recognition material and production method thereof | Shiseido Co., Ltd. (JP) | 2012-09-19 | — | — | EP | disclosed |
| US-5821260-A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | EMORY UNIVERSITY (US) | 1998-10-13 | — | — | US | disclosed |
| US-5811449-A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | EMORY UNIVERSITY (US) | 1998-09-22 | — | — | US | disclosed |
| US-5807884-A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | EMORY UNIVERSITY (US) | 1998-09-15 | — | — | US | disclosed |
| US-5792787-A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | EMORY UNIVERSITY (US) | 1998-08-11 | — | — | US | disclosed |
| US-5783596-A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | EMORY UNIVERSITY (US) | 1998-07-21 | — | — | US | disclosed |
| US-5773209-A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | EMORY UNIVERSITY (US) | 1998-06-30 | — | — | US | disclosed |
| US-5750351-A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | EMORY UNIVERSITY (US) | 1998-05-12 | — | — | US | disclosed |
| US-5380747-A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | EMORY UNIVERSITY (US) | 1995-01-10 | — | — | US | disclosed |
| US-5358703-A | Forming a paramagnetic complex with a dithiocarbamate and reduced iron ions; magnetic resonance imaging | MCW RESEARCH FOUNDATION, INC. (US) | 1994-10-25 | — | — | US | disclosed |
| US-5002755-A | Administering A Dithiocarbamate Chelator | VANDERBILT UNIVERSITY (US) | 1991-03-26 | — | — | US | disclosed |